Literature DB >> 18496356

Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock.

Michael Fries1, Can Ince, Rolf Rossaint, Christian Bleilevens, Johannes Bickenbach, Steffen Rex, Egbert G Mik.   

Abstract

OBJECTIVE: To determine the effects of norepinephrine and levosimendan on microvascular perfusion and oxygenation in a rat model of septic shock.
DESIGN: Controlled laboratory animal study.
SETTING: Research laboratory in a university hospital.
SUBJECTS: Forty Sprague-Dawley rats.
INTERVENTIONS: Sepsis was induced in 32 animals by cecal ligation and puncture. Eight animals served as sham controls. Animals were randomly assigned to five groups: 1) fluid resuscitation (25 ml x kg(-1) x h(-1)), 2) fluid resuscitation plus norepinephrine (0.5 microg x kg(-1) x min(-1)), 3) fluid resuscitation plus levosimendan (0.3 microg x kg(-1) x min(-1)), 4) no treatment and 5) sham control.
MEASUREMENTS AND MAIN RESULTS: Microvascular perfusion was quantitated using sidestream darkfield imaging and microvascular oxygenation (microPO2) was assessed by oxygen-dependent quenching of phosphorescence. Measurements were obtained on the buccal mucosa at baseline and at hourly intervals thereafter. In parallel, cardiac output (CO) was recorded. After induction of sepsis microvascular perfusion and microPO2 were impaired early followed by significant decreases in CO. Although levosimendan and norepinephrine were equally effective in restoring CO, only treatment with levosimendan significantly improved microPO2 after 1 and 2 hours of treatment (9.7 +/- 2.0 vs. 15.1 +/- 2.6 and 16.0 +/- 3.7 mmHg; p < 0.05). Microvascular perfusion was not significantly influenced by any of the treatment strategies.
CONCLUSIONS: In this model, treatment with levosimendan and norepinephrine showed comparable effects in restoring CO and had no significant influence on microvascular perfusion. However, only levosimendan significantly improved microPO2, suggesting that a mechanism relatively independent of macrocirculatory hemodynamics and overall microvascular perfusion might account for these observations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18496356     DOI: 10.1097/CCM.0b013e31817cede9

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

Review 1.  The dynamic regulation of microcirculatory conduit function: features relevant to transfusion medicine.

Authors:  Arif Somani; Marie E Steiner; Robert P Hebbel
Journal:  Transfus Apher Sci       Date:  2010-06-26       Impact factor: 1.764

Review 2.  Sepsis: in search of cure.

Authors:  Chikkamenahalli Lakshminarayana Lakshmikanth; Shancy Petsel Jacob; Vyala Hanumanthareddy Chaithra; Hugo Caire de Castro-Faria-Neto; Gopal Kedihithlu Marathe
Journal:  Inflamm Res       Date:  2016-03-19       Impact factor: 4.575

Review 3.  The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients.

Authors:  E Christiaan Boerma; Can Ince
Journal:  Intensive Care Med       Date:  2010-09-02       Impact factor: 17.440

4.  Effects of intravenous and inhaled levosimendan in severe rodent sepsis.

Authors:  Patrick Scheiermann; Devan Ahluwalia; Sandra Hoegl; Andrea Dolfen; Marc Revermann; Bernhard Zwissler; Heiko Muhl; Kim A Boost; Christian Hofstetter
Journal:  Intensive Care Med       Date:  2009-04-15       Impact factor: 17.440

5.  The microcirculation in sepsis.

Authors:  Asha Tyagi; Ashok Kumar Sethi; Gautam Girotra; Medha Mohta
Journal:  Indian J Anaesth       Date:  2009-06

6.  Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study.

Authors:  Andrea Morelli; Abele Donati; Christian Ertmer; Sebastian Rehberg; Matthias Lange; Alessandra Orecchioni; Valeria Cecchini; Giovanni Landoni; Paolo Pelaia; Paolo Pietropaoli; Hugo Van Aken; Jean-Louis Teboul; Can Ince; Martin Westphal
Journal:  Crit Care       Date:  2010-12-23       Impact factor: 9.097

7.  Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model.

Authors:  Cheng-Ming Tsao; Kai-Yi Li; Shiu-Jen Chen; Shuk-Man Ka; Wen-Jinn Liaw; Hsieh-Chou Huang; Chin-Chen Wu
Journal:  Crit Care       Date:  2014-11-29       Impact factor: 9.097

8.  Levosimendan increases brain tissue oxygen levels after cardiopulmonary resuscitation independent of cardiac function and cerebral perfusion.

Authors:  Andreas García-Bardon; Jens Kamuf; Alexander Ziebart; Tanghua Liu; Nadia Krebs; Bastian Dünges; Robert F Kelm; Svenja Morsbach; Kristin Mohr; Axel Heimann; Erik K Hartmann; Serge C Thal
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

9.  To beta block or not to beta block; that is the question.

Authors:  Can Ince
Journal:  Crit Care       Date:  2015-09-24       Impact factor: 9.097

10.  An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial.

Authors:  Robert M L'E Orme; Gavin D Perkins; Daniel F McAuley; Kathleen D Liu; Alexina J Mason; Andrea Morelli; Mervyn Singer; Deborah Ashby; Anthony C Gordon
Journal:  Trials       Date:  2014-06-02       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.